Rezultati - Werd Al‐Najim

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Health Benefits Beyond the Scale: The Role of Diet and Nutrition During Weight Loss Programmes

    Health Benefits Beyond the Scale: The Role of Diet and Nutrition During Weight Loss Programmes od F Contreras, Werd Al‐Najim, Carel W. le Roux

    Izdano 2024
    Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  2. 2
    Food Intake and Eating Behavior After Bariatric Surgery

    Food Intake and Eating Behavior After Bariatric Surgery od Werd Al‐Najim, Neil G. Docherty, Carel W. le Roux

    Izdano 2018
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  3. 3
    The Effect of a Subcutaneous Infusion of GLP-1, OXM, and PYY on Energy Intake and Expenditure in Obese Volunteers

    The Effect of a Subcutaneous Infusion of GLP-1, OXM, and PYY on Energy Intake and Expenditure in Obese Volunteers od Tricia Tan, Preeshila Behary, George Tharakan, James Minnion, Werd Al‐Najim, Nicolai J. Wewer Albrechtsen, Jens J. Holst, Stephen R. Bloom

    Izdano 2017
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  4. 4
    Effectiveness of integrating a pragmatic pathway for prescribing liraglutide 3.0 mg in weight management services (STRIVE study): a multicentre, open-label, parallel-group, randomized controlled trial

    Effectiveness of integrating a pragmatic pathway for prescribing liraglutide 3.0 mg in weight management services (STRIVE study): a multicentre, open-label, parallel-group, randomi... od Dimitris Papamargaritis, Werd Al‐Najim, Jonathan Lim, James P. Crane, Danielle H. Bodicoat, Shaun Barber, Michael E. J. Lean, Barbara McGowan, Donal O’Shea, David R. Webb, John Wilding, Carel W. le Roux, Melanie J. Davies

    Izdano 2024
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  5. 5
    Adjunctive liraglutide treatment in patients with persistent or recurrent type 2 diabetes after metabolic surgery (GRAVITAS): a randomised, double-blind, placebo-controlled trial

    Adjunctive liraglutide treatment in patients with persistent or recurrent type 2 diabetes after metabolic surgery (GRAVITAS): a randomised, double-blind, placebo-controlled trial od Alexander D. Miras, Belén Pérez‐Pevida, Madhawi Aldhwayan, Anna Kamocka, Emma Rose McGlone, Werd Al‐Najim, Harvinder Chahal, Rachel L. Batterham, Barbara McGowan, Omar Khan, Veronica Greener, Ahmed R. Ahmed, Aviva Petrie, Samantha Scholtz, Stephen R. Bloom, Tricia Tan

    Izdano 2019
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:

Iskalna orodja: